Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar unusualpro (< 20) Submitted: 1/23/2011 12:02:38 AM : Outperform Start Price: $1.90 ARNA Score: +212.82

Bravo Pick.

Featured Broker Partners


Advertisement